These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4876444)

  • 1. Irreversible enzyme inhibitors. CXXXI. Cytosine nucleoside deaminase. II. Hydrophobic bonding with disubstituted uracils and cytosines.
    Baker BR; Kelley JL
    J Med Chem; 1968 Jul; 11(4):686-90. PubMed ID: 4876444
    [No Abstract]   [Full Text] [Related]  

  • 2. Irreversible enzyme inhibitors. CXXX. Cytosine nucleoside deaminase. I. Hydrophobic bonding with monosubstituted uracils.
    Baker BR; Kelley JL
    J Med Chem; 1968 Jul; 11(4):682-6. PubMed ID: 4876443
    [No Abstract]   [Full Text] [Related]  

  • 3. Irreversible enzyme inhibitors. CLXII. Hydrophobic bonding to cytosine nucleoside deaminase with 1-substituted 5-arylcytosines.
    Baker BR; Kelley JL
    J Med Chem; 1969 Nov; 12(6):1039-45. PubMed ID: 5351445
    [No Abstract]   [Full Text] [Related]  

  • 4. Irreversible enzyme inhibitors. 73. Active-site-directed irreversible inhibitors of cytosine nucleoside deaminase derived from 1-phenoxypropyl-5-arylcytosines.
    Baker BR; Kelley JL
    J Med Chem; 1969 Nov; 12(6):1046-9. PubMed ID: 5351446
    [No Abstract]   [Full Text] [Related]  

  • 5. Irreversible enzyme inhibitors. CXXI. Thymidine phosphorylase. IX. On the nature and dimensions of the hydrophobic bonding region.
    Baker BR; Rzeszotarski W
    J Med Chem; 1968 Jul; 11(4):639-44. PubMed ID: 4876442
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzyme inhibitors. XX. Studies on the hydrophobic and hydroxyl binding regions of adenosine deaminase. 9-(2-m-Bromoacetamidophenethyl)adenine, a new irreversible inhibitor of adenosine deaminase.
    Schaeffer HJ; Johnson RN
    J Med Chem; 1968 Jan; 11(1):21-6. PubMed ID: 5637186
    [No Abstract]   [Full Text] [Related]  

  • 7. Enzyme inhibitors XXIV: bridging hydrophobic and hydrophilic regions on adenosine deaminase.
    Schaeffer HJ; Schwender CF
    J Pharm Sci; 1971 Aug; 60(8):1204-8. PubMed ID: 5156472
    [No Abstract]   [Full Text] [Related]  

  • 8. Irreversible enzyme inhibitors. 99. Inhibitors of thymidine phosphorylase. 7. Further studies on hydrophobic bonding with hydrocarbon substituents on acidic uracils.
    Baker BR; Kawazu M; McClure JD
    J Pharm Sci; 1967 Sep; 56(9):1081-6. PubMed ID: 6049691
    [No Abstract]   [Full Text] [Related]  

  • 9. Irreversible enzyme inhibitors. CII. On the mode of phenyl binding of 9-phenylguanine to guanine deaminase and xanthine oxidase.
    Baker BR; Wood WF
    J Med Chem; 1967 Nov; 10(6):1101-5. PubMed ID: 6056037
    [No Abstract]   [Full Text] [Related]  

  • 10. Irreversible enzyme inhibitors. CIV. Inhibitors of thymidine phosphorylase. 8. Further studies on hydrophobic bonding with 6-substituted uracils.
    Baker BR; Rzeszotarski W
    J Med Chem; 1967 Nov; 10(6):1109-13. PubMed ID: 6056039
    [No Abstract]   [Full Text] [Related]  

  • 11. Enzyme inhibitors. XXI. Hydrophobic and hydroxylic binding sites of adenosine deaminase.
    Schaeffer HJ; Schwender CF
    J Pharm Sci; 1967 Dec; 56(12):1586-90. PubMed ID: 5588708
    [No Abstract]   [Full Text] [Related]  

  • 12. Irreversible enzyme inhibitors. 148. Active-site-directed irreversible inhibitors of guanine deaminase derived from 9-phenylguanine bearing a terminal sulfonyl fluoride.
    Baker BR; Wood WF
    J Med Chem; 1969 Mar; 12(2):216-20. PubMed ID: 5783593
    [No Abstract]   [Full Text] [Related]  

  • 13. Enzyme inhibitors. 23. Syntheses of 9-(substituted aralkyl)-6-substituted purines as inhibitors of adenosine deaminase.
    Schaeffer HJ; Odin E; Bittner S
    J Pharm Sci; 1971 Aug; 60(8):1184-8. PubMed ID: 5127092
    [No Abstract]   [Full Text] [Related]  

  • 14. Enzyme inhibitors. XXII. Identity of inhibitor binding site on adenosine deaminase.
    Schaeffer HJ; Schwender CF
    J Pharm Sci; 1968 Jun; 57(6):1070-2. PubMed ID: 5671335
    [No Abstract]   [Full Text] [Related]  

  • 15. Strand-biased cytosine deamination at the replication fork causes cytosine to thymine mutations in Escherichia coli.
    Bhagwat AS; Hao W; Townes JP; Lee H; Tang H; Foster PL
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2176-81. PubMed ID: 26839411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification & properties of cytosine nucleoside deaminase from green gram (Phaseolus aureus) seedlings.
    Achar BS; Maller RK; Vaidyanathan CS
    Indian J Biochem; 1966 Sep; 3(3):133-8. PubMed ID: 4227100
    [No Abstract]   [Full Text] [Related]  

  • 17. Irreversible enzyme inhibitors. 103. 9-(p-Bromoacetamidophenyl)guanine, an irreversible inhibitor of xanthine oxidase.
    Baker BR; Wood WF
    J Med Chem; 1967 Nov; 10(6):1106-9. PubMed ID: 6056038
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of 6,9-disubstituted 8-azapurines on adenosine deaminase, guanine deaminase and xanthine oxidase.
    Lucacchini A; Bazzichi L; Biagi G; Livi O; Segnini D
    Ital J Biochem; 1982; 31(3):153-62. PubMed ID: 6897062
    [No Abstract]   [Full Text] [Related]  

  • 19. Enzyme inhibitors. XIX. The synthesis of some 1-hydroxy-2-hydroxymethyl-4-(6-substituted-9-purinyl)cyclohexanes as nucleoside analogs.
    Schaeffer HJ; Vince R
    J Med Chem; 1968 Jan; 11(1):15-20. PubMed ID: 5637163
    [No Abstract]   [Full Text] [Related]  

  • 20. New guanine deaminase inhibitors.
    Saxena AK; Ahmad S; Shanker K; Kishor K
    Pharmacol Res Commun; 1984 Mar; 16(3):243-52. PubMed ID: 6718460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.